The 3rd Edition of the India Pharma Week Gears up for a Grand Debut in Delhi-NCR

/ -- A week full of avant-garde events alongside the 12th edition of CPhI & P-MEC India to take place at the India Expo Mart, Greater Noida
(Logo: https://mma.prnewswire.com/media/675607/UBM_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/789327/India_Pharma_Week_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/789348/CPhI_P_MEC_India_Logo.jpg )
(Logo: https://mma.prnewswire.com/media/789328/India_Pharma_Awards_Logo.jpg )
Speaking on IPW 2018, Mr. Yogesh Mudras, Managing Director, UBM India said, "I am delighted to announce the third edition of the weeklong India Pharma Week -- an unrivalled offering to the world of exhibitions -- along with the CPhI & P-MEC India, UBM's flagship engagement platform, and the world's leading Pharmaceutical networking event in the Delhi-NCR region at a world-class venue that an elite congress such as the one at IPW richly deserve. The shift to the region, in close geographical proximity to the Centre, policy makers, consulates and government bodies will enhance our community building efforts. Apart from the business, and the medley of captivating events, key discussion areas will include 'Growth of Indian Pharmaceutical industry: Vision 2020', 'Transforming the Pharma industry architecture through collaborations', and 'Strategies to strengthen regulatory policies in India' among many others, for the community to ruminate and act upon."

"With an estimated spend of over US$ 200 billion on medical infrastructure in the next decade; India is keen to make drugs affordable as well as available in all corners of the country. What is also equally required to make India a global leader in end to end pharma manufacturing, as encapsulated by The 'Pharma Vision 2020' is a heightened appreciation and awareness about compliance requirements and investment in R&D. These factors seem to have been comprehended by the pharma community with around 9 per cent of sales by organisations being re-invested in R&D and 46 mergers having been affected in 2017-18. These will, no doubt, go a long way in leading the country on to further innovation, discovery and patents to maintain its stronghold over the sector," he further added

Events under IPW:

About the CPhI & P-MEC expo:
About India Pharma Week:
About UBM Asia: